Explore

Trendline Trendline
DiaMedica Therapeutics Reports Q1 2026 Financial Results and Clinical Progress

DiaMedica Therapeutics Reports Q1 2026 Financial Results and Clinical Progress

DiaMedica Therapeutics Reports Q1 2026 Financial Results and Clinical Progress
Trendline Trendline
Epirium Bio Unveils Promising Preclinical Data on 15-PGDH Inhibitors for Inflammatory Bowel Disease

Epirium Bio Unveils Promising Preclinical Data on 15-PGDH Inhibitors for Inflammatory Bowel Disease

Epirium Bio Unveils Promising Preclinical Data on 15-PGDH Inhibitors for Inflammatory Bowel Disease
Trendline Trendline
IDEAYA Biosciences Reports Positive Results and Business Updates for Q1 2026

IDEAYA Biosciences Reports Positive Results and Business Updates for Q1 2026

IDEAYA Biosciences Reports Positive Results and Business Updates for Q1 2026
Trendline Trendline
Travere Therapeutics Reports Significant Growth in Q1 2026 Financial Results

Travere Therapeutics Reports Significant Growth in Q1 2026 Financial Results

Travere Therapeutics Reports Significant Growth in Q1 2026 Financial Results
Trendline Trendline
Curis to Announce Q1 2026 Financial Results and Host Webcast

Curis to Announce Q1 2026 Financial Results and Host Webcast

Curis to Announce Q1 2026 Financial Results and Host Webcast
Trendline Trendline
Vir Biotechnology to Present at Bank of America Securities 2026 Healthcare Conference

Vir Biotechnology to Present at Bank of America Securities 2026 Healthcare Conference

Vir Biotechnology to Present at Bank of America Securities 2026 Healthcare Conference
Trendline Trendline
Vir Biotechnology to Present at Bank of America Healthcare Conference

Vir Biotechnology to Present at Bank of America Healthcare Conference

Vir Biotechnology to Present at Bank of America Healthcare Conference
Trendline Trendline
NImmune Biopharma Presents Promising Data on NIM-1324 for IBD at Digestive Disease Week 2026

NImmune Biopharma Presents Promising Data on NIM-1324 for IBD at Digestive Disease Week 2026

NImmune Biopharma Presents Promising Data on NIM-1324 for IBD at Digestive Disease Week 2026
Trendline Trendline
Epicrispr and Forge Biologics Partner for AAV Development and Manufacturing

Epicrispr and Forge Biologics Partner for AAV Development and Manufacturing

Epicrispr and Forge Biologics Partner for AAV Development and Manufacturing
Trendline Trendline
Vertex Receives 2026 Kidney Biotech Innovation Award for Advancements in Kidney Disease Treatment

Vertex Receives 2026 Kidney Biotech Innovation Award for Advancements in Kidney Disease Treatment

Vertex Receives 2026 Kidney Biotech Innovation Award for Advancements in Kidney Disease Treatment
Trendline Trendline
UCB Acquires Candid Therapeutics for $2 Billion to Expand T-Cell Engager Therapies

UCB Acquires Candid Therapeutics for $2 Billion to Expand T-Cell Engager Therapies

UCB Acquires Candid Therapeutics for $2 Billion to Expand T-Cell Engager Therapies
Trendline Trendline
Mapi Pharma Plans U.S. Aseptic Manufacturing Facility to Meet Growing Demand for Injectables

Mapi Pharma Plans U.S. Aseptic Manufacturing Facility to Meet Growing Demand for Injectables

Mapi Pharma Plans U.S. Aseptic Manufacturing Facility to Meet Growing Demand for Injectables